Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$51.95
+2.9%
$52.57
$43.38
$62.88
$7.03B1.11830,213 shs1.06 million shs
Haemonetics Co. stock logo
HAE
Haemonetics
$94.40
+1.1%
$82.36
$70.74
$95.26
$4.79B0.34429,361 shs368,663 shs
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$28.89
+0.5%
$33.75
$27.18
$51.12
$2.27B1.17858,626 shs1.47 million shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$99.99
+1.0%
$100.98
$78.28
$212.43
$2.44B0.72194,470 shs165,174 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$44.72
+22.3%
$32.29
$13.82
$47.00
$2.89B1.11.28 million shs5.99 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
+2.91%+2.77%-0.75%+0.23%-8.55%
Haemonetics Co. stock logo
HAE
Haemonetics
+1.10%+3.78%+12.53%+23.72%+15.44%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
+0.49%+1.94%-14.78%-28.08%-43.74%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+0.96%+5.43%-3.26%+9.83%-46.72%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+22.32%+26.90%+30.53%+92.59%+11.94%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.8492 of 5 stars
3.32.00.04.12.74.23.1
Haemonetics Co. stock logo
HAE
Haemonetics
4.03 of 5 stars
2.32.00.04.32.71.72.5
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.7987 of 5 stars
3.13.00.04.02.81.73.8
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.7877 of 5 stars
2.51.00.03.92.62.51.9
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
3.1857 of 5 stars
2.32.00.04.93.40.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.67
Moderate Buy$66.3327.69% Upside
Haemonetics Co. stock logo
HAE
Haemonetics
2.50
Moderate Buy$104.6710.88% Upside
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
2.22
Hold$44.8955.38% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$123.0023.01% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.64
Moderate Buy$43.45-2.83% Downside

Current Analyst Ratings

Latest IART, TNDM, GMED, ICUI, and HAE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$35.00 ➝ $50.00
5/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$28.00 ➝ $36.00
4/29/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$21.00 ➝ $45.00
4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$34.00 ➝ $45.00
4/23/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$37.00 ➝ $40.00
4/12/2024
Haemonetics Co. stock logo
HAE
Haemonetics
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00
4/3/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$38.00
4/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$31.00 ➝ $38.00
3/26/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00 ➝ $37.00
3/18/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.02B6.89$3.71 per share13.99$29.32 per share1.77
Haemonetics Co. stock logo
HAE
Haemonetics
$1.17B4.10$5.03 per share18.76$16.22 per share5.82
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.54B1.47$4.86 per share5.95$20.31 per share1.42
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.26B1.08$15.45 per share6.47$87.96 per share1.14
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$747.72M3.86N/AN/A$4.81 per share9.30

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.1744.4015.841.497.83%8.82%7.20%5/7/2024 (Confirmed)
Haemonetics Co. stock logo
HAE
Haemonetics
$115.40M$2.4638.3722.262.209.97%22.37%9.71%5/9/2024 (Confirmed)
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M$0.8334.818.000.874.39%15.19%6.59%5/6/2024 (Confirmed)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$1.23N/A18.59N/A-1.31%6.35%3.03%5/7/2024 (Confirmed)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$2.17N/AN/AN/A-18.37%-32.33%-10.90%8/1/2024 (Estimated)

Latest IART, TNDM, GMED, ICUI, and HAE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Haemonetics Co. stock logo
HAE
Haemonetics
$0.88N/A-$0.88N/AN/AN/A  
5/7/2024N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.55N/A-$0.55N/AN/AN/A  
5/7/2024N/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.8350N/A-$0.8350N/AN/AN/A  
5/6/2024N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.55N/A-$0.55N/AN/AN/A  
2/28/202412/31/2023
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.90$0.89-$0.01$1.53$399.30 million$397.00 million    
2/27/2024Q4 2023
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.85$1.24+$0.39$3.19$564.77 million$587.86 million
2/21/2024Q4 2023
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.23-$0.27-$0.04-$0.08$204.86 million$196.80 million
2/20/2024Q4 2023
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    
2/8/202412/31/2023
Haemonetics Co. stock logo
HAE
Haemonetics
$0.94$1.04+$0.10$1.47$320.84 million$336.20 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Haemonetics Co. stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.10
4.88
2.72
Haemonetics Co. stock logo
HAE
Haemonetics
0.91
2.92
1.76
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.94
3.45
2.18
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.74
2.53
1.06
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.91
3.83
3.02

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Haemonetics Co. stock logo
HAE
Haemonetics
99.67%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
24.30%
Haemonetics Co. stock logo
HAE
Haemonetics
1.79%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3.10%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
6.70%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million102.48 millionOptionable
Haemonetics Co. stock logo
HAE
Haemonetics
3,03450.79 million49.88 millionOptionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,94678.60 million76.17 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,00024.36 million22.73 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,40064.56 million63.14 millionOptionable

IART, TNDM, GMED, ICUI, and HAE Headlines

SourceHeadline
Tandem Diabetes Care (NASDAQ:TNDM) Sets New 52-Week High Following Analyst UpgradeTandem Diabetes Care (NASDAQ:TNDM) Sets New 52-Week High Following Analyst Upgrade
americanbankingnews.com - May 4 at 1:38 AM
Why Tandem Diabetes Stock Just Jumped 22%Why Tandem Diabetes Stock Just Jumped 22%
fool.com - May 3 at 4:34 PM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call TranscriptTandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 3 at 1:09 PM
Tandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month High After Analyst UpgradeTandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month High After Analyst Upgrade
marketbeat.com - May 3 at 12:51 PM
Tandem Diabetes Care (NASDAQ:TNDM) Earns "Overweight" Rating from Piper SandlerTandem Diabetes Care (NASDAQ:TNDM) Earns "Overweight" Rating from Piper Sandler
marketbeat.com - May 3 at 11:12 AM
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises 24 ViewTandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
zacks.com - May 3 at 10:36 AM
Tandem Diabetes Care (NASDAQ:TNDM) PT Raised to $36.00Tandem Diabetes Care (NASDAQ:TNDM) PT Raised to $36.00
marketbeat.com - May 3 at 9:33 AM
Tandem Diabetes Care Shares Rise 17% on Raised 2024 Sales OutlookTandem Diabetes Care Shares Rise 17% on Raised 2024 Sales Outlook
marketwatch.com - May 3 at 8:08 AM
Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
finance.yahoo.com - May 3 at 8:08 AM
Q1 2024 Tandem Diabetes Care Inc Earnings CallQ1 2024 Tandem Diabetes Care Inc Earnings Call
finance.yahoo.com - May 3 at 8:08 AM
TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024
investorplace.com - May 2 at 10:05 PM
Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesTandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - May 2 at 7:31 PM
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue EstimatesTandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
zacks.com - May 2 at 6:31 PM
Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial GuidanceTandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
businesswire.com - May 2 at 4:05 PM
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY)Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY)
markets.businessinsider.com - May 2 at 8:23 AM
Tandem Diabetes Care (NASDAQ:TNDM) Stock Rating Upgraded by Wells Fargo & CompanyTandem Diabetes Care (NASDAQ:TNDM) Stock Rating Upgraded by Wells Fargo & Company
americanbankingnews.com - May 1 at 9:46 AM
How Advanced Diabetes Supply is Driving Value-Based Health OutcomesHow Advanced Diabetes Supply is Driving Value-Based Health Outcomes
hmenews.com - April 30 at 5:21 PM
Wells Fargo Upgrades Tandem Diabetes Care (TNDM)Wells Fargo Upgrades Tandem Diabetes Care (TNDM)
msn.com - April 30 at 12:21 PM
Are Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?Are Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?
finance.yahoo.com - April 29 at 4:19 PM
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $35.24
marketbeat.com - April 29 at 12:12 PM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded to Overweight at Wells Fargo & CompanyTandem Diabetes Care (NASDAQ:TNDM) Upgraded to Overweight at Wells Fargo & Company
marketbeat.com - April 29 at 8:06 AM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at Leerink PartnrsTandem Diabetes Care (NASDAQ:TNDM) Upgraded at Leerink Partnrs
americanbankingnews.com - April 27 at 3:48 AM
Tandem Diabetes Care (NASDAQ:TNDM) Rating Increased to Outperform at SVB LeerinkTandem Diabetes Care (NASDAQ:TNDM) Rating Increased to Outperform at SVB Leerink
americanbankingnews.com - April 27 at 1:54 AM
Leerink Partners Upgrades Tandem Diabetes Care (TNDM)Leerink Partners Upgrades Tandem Diabetes Care (TNDM)
msn.com - April 26 at 1:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Haemonetics logo

Haemonetics

NYSE:HAE
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Integra LifeSciences logo

Integra LifeSciences

NASDAQ:IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
ICU Medical logo

ICU Medical

NASDAQ:ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Tandem Diabetes Care logo

Tandem Diabetes Care

NASDAQ:TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.